|
|
||||||||
1 Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1083; and 2 Institute of Human Physiology and Clinical Experimental Research, Semmelweis University, Budapest, Hungary 1082
| |
ABSTRACT |
|---|
|
|
|---|
We investigated effects of diazoxide, a selective opener of mitochondrial ATP-sensitive K+ (mitoKATP) channels, against brain damage after middle cerebral artery occlusion (MCAO) in male Wistar rats. Diazoxide (0.4 or 2 mM in 30 µl saline) or saline (sham) was infused into the right lateral ventricle 15 min before MCAO. Neurological score was improved 24 h later in the animals treated with 2 mM diazoxide (13.8 ± 0.7, n = 13) compared with sham treatment (9.5 ± 0.2, n = 6, P < 0.01). The total percent infarct volume (MCAO vs. contralateral side) of sham treatment animals was 43.6 ± 3.6% (n = 12). Treatment with 2 mM diazoxide reduced the infarct volume to 20.9 ± 4.8% (n = 13, P < 0.05). Effects of diazoxide were prominent in the cerebral cortex. The protective effect of diazoxide was completely prevented by the pretreatment with 5-hydroxydecanoate (100 mM in 10 µl saline), a selective blocker of mitoKATP channels (n = 6). These results indicate that selective opening of the mitoKATP channel has neuroprotective effects against ischemia-reperfusion injury in the rat brain.
ischemia; stroke; cerebral circulation; mitochondrial adenosine 5'-triphosphate-sensitive potassium channels
| |
INTRODUCTION |
|---|
|
|
|---|
WHILE THE MAIN FUNCTION of mitochondria is ATP synthesis, these intracellular organelles also play a major role in mediating cellular responses to ischemic stress. For example, calcium influx into mitochondria and the opening of mitochondrial permeability transition pores appear to be early steps leading to necrotic and apoptotic cell death in various tissues and organs including the brain (19, 29). Additionally, numerous studies have shown that the pharmacological targeting of mitochondrial ATP-sensitive K+ (mitoKATP) channels, with acute administration of drugs such as diazoxide, protects ischemic myocardium against injury (17, 30). Diazoxide is a selective opener of mitoKATP channels and has minimal effects on sarcolemmal KATP channels (10, 20, 31). Furthermore, transient activation of mitoKATP channels with sublethal ischemia appears to be a crucial step in the development of ischemic preconditioning, which protects myocytes from subsequent prolonged ischemia (15, 17). Protective effects of acute administration of diazoxide or ischemic preconditioning can be prevented by 5-hydroxydecanoate (5-HD), a selective antagonist of mitoKATP channels (15, 20, 31), whereas a selective inhibitor of sarcolemmal KATP channels has no protective effect (15). While the mechanism of acute cellular protection by diazoxide is not completely understood, one possible explanation is that the opening of the mitoKATP channel minimizes calcium influx, mitochondrial swelling, and subsequent injury by depolarizing the membranes of these organelles (15, 21, 35).
In contrast to the heart, little is known about possible cellular protective effects of mitoKATP channel activation in the brain. For example, only two studies have specifically targeted mitoKATP channels in an attempt to protect the brain against ischemic or anoxic stresses. Thus Domoki et al. (13) have shown that diazoxide administration preserves neuronal function after 10 min of ischemic stress in the piglet cerebral cortex. This protective effect was reversed with coapplication of 5-HD. In the other study, diazoxide prevented cell injury in brain slices during 30 min of anoxia (4). We are unaware of any previous reports except for our own preliminary findings (7, 38) concerning the effects of mitoKATP channel opening on infarct volume after ischemia-reperfusion injury in the brain.
In the present study, we explored the potential for the
mitoKATP channel to protect the brain against
ischemic insult. First, we used immunoblotting techniques to
establish the presence of essential subunits (inward rectifying
K+ channel and sulfonylurea receptor) of the
KATP channel on brain mitochondria. We chose to examine the
Kir6.1 and sulfonylurea receptor (SUR)2 subunits based on previous
studies (5, 47) and pilot experiments. Second, we
evaluated the direct effect of diazoxide on membrane potential
(
m) of rat brain isolated mitochondria using
fluorescent approaches. Third, we investigated whether pharmacological
opening of the mitoKATP channel would limit
ischemic damage after transient middle cerebral artery (MCA) occlusion (MCAO) in the rat. Finally, we examined the effects of
diazoxide on cerebral blood flow (CBF) and arterial blood pressure during control, ischemic, and postischemic conditions.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
All experiments were performed on male Wistar rats weighing 190-210 g. The procedures were approved by the Institutional Animal Care and Use Committee.
Mitochondria preparation.
Pure, isolated mitochondria preparations from the rat brain were
collected using a discontinuous percoll gradient method (27, 37,
41). This protocol offers sufficient yield with very low contamination from other organelles (1-4%), as demonstrated by electron microscopy and by Western blotting for proteins associated with contaminating structures (27, 34). Additionally, we
have shown that mitochondria isolated by this method maintain a

m, have normal respiratory values, and continue to
import proteins via an energy-dependent mechanism (34).
Adult male Wistar rats were anesthetized with thiopental sodium (250 mg/kg ip) and decapitated. The brain was removed and homogenized by
eight strokes of a Teflon-glass motorized tissue grinder (Wheaton;
Milville, NJ) in isolation buffer containing 12% percoll (Amersham
Pharmacia; Uppsala, Sweden). Mitochondria were isolated in sucrose
buffer containing 0.32 M sucrose, 1 mM EDTA, and 10 mM
Tris · HCl; pH 7.4. The resulting suspension was centrifuged
for 3 min at 3,000 rpm, and the middle layer was saved and layered on
top of a discontinuous percoll gradient (24/40%). The gradient was
centrifuged for 5 min at 19,000 rpm, and the third layer containing the
purified mitochondria was collected. The preparation was washed in
isolation buffer and centrifuged for 10 min at 14,000 rpm, and the
pellet was used for further investigations. All procedures were
performed on ice.
Western blotting. Protein was extracted from freshly isolated mitochondria by the addition of boiling lysis buffer [containing 1% (vol/vol) of 1 mol/l Tris and 1% (wt/vol) sodium dodecyl sulphate]. The samples were sonicated, heated at 95°C for 5 min, and centrifuged for 20 min at 12,000 rpm at 4°C. The supernatant was used for immunoblotting. Protein concentration was measured by a Bio-Rad DC protein assay kit (Bio-Rad Laboratories; Hercules, CA). An equal volume of sample buffer [45% (vol/vol) of 0.5 mol/l Tris (pH 6.8), 45% (vol/vol) glycerol, 10% (vol/vol) H2O, 0.75 mg/ml bromophenol blue, and 90 mg/ml sodium dodecyl sulphate] was added to each sample. Equal amounts of protein were separated on a 4-20% gradient mini gel (Bio-Rad) and transferred to a polyvinylidene difluoride membrane. After the membrane was blocked with 3% bovine serum albumin, primary antibodies against the KATP receptor subunits Kir6.1 or SUR2 (Santa Cruz Biotechnology; Santa Cruz, CA) were applied followed by horseradish peroxidase-conjugated secondary antibody. Chemiluminescence was used to visualize the bands. Molecular mass markers (Bio-Rad) were included on each blot. Specificity of the method was tested by omitting the primary antibody from the procedure or preabsorption with the respective blocking peptides, which resulted in the disappearance of the specific bands (data not shown).
Fluorescent microscopy.
Freshly isolated mitochondria were dispersed in buffer containing 125 mM KCl, 2 mM K2HPO4, 5 mM MgCl2, 10 mM HEPES, 10 µM EGTA, 5 mM Na-malate, and 5 mM Na-glutamate at pH
7.0. The mitochondria were visualized using a Zeiss scanning confocal
microscope with a fluorescein filter set. Mitochondrial

m was monitored by the addition of 2 µg/ml
rhodamine-1,2,3 (36). Three subsequent images were
recorded from each preparation: 1) baseline, 2)
with the addition of diazoxide (0.1 mM), and 3) with the
addition of nigericin (0.01 mM). The ionophore nigericin served as a
positive control, because it fully decreases the transmembrane proton
gradient (
pH) and converts it to 
m. Mitochondrial
autofluorescence was routinely recorded in each preparation before
adding rhodamine-1,2,3. The intensity of autofluorescence of the
mitochondria was negligible compared with the intensity after addition
of rhodamine-1,2,3.
MCAO experiments.
Animals were fasted overnight with access to water before surgery.
After anesthesia was induced with 5% halothane in 95% oxygen, endotracheal intubation was performed, and all the animals were mechanically ventilated with 1.0-1.5% halothane in a 70:30 gas mixture of N2O and O2 (SAR-830 Ventilator,
CWE). The tail artery was cannulated for continuous monitoring of mean
arterial blood pressure (MABP; model 300, Blood Pressure Analyzer,
Digi-Med) and intermittent sampling of arterial blood for determination of gases and pH. The head was then stabilized in a stereotactic frame,
and a hole was made in the skull. A total amount of 30 µl diazoxide
(0.4 mM, n = 6, or 2 mM, n = 13) was
infused into the right lateral ventricle (AP,
0.8 mm, lateral 1.5 mm,
and dorsoventral 3.5 mm), according to the rat brain atlas
(32) 15 min before the induction of ischemia
(9). Diazoxide was initially dissolved in a small amount
of dimethyl sulfoxide (DMSO) and further diluted in buffered saline.
Additionally, we studied a sham-treated group (n = 12)
in which one-half of the rats were treated with 30 µl buffered saline
alone and the other half were treated with an appropriate amount of
DMSO in 30 µl buffered saline. This amount of DMSO corresponded to
that administered with the higher dose of diazoxide. Because there were
no substantial differences in total infarct volume between these two
vehicle groups (41.9 ± 6.7% saline alone vs. 45.3 ± 7.1%
DMSO in saline), the data were combined into one sham group. Finally,
we examined the specificity of the effect of diazoxide using the
mitochondrial KATP channel inhibitor 5-HD. Ten microliters
of 100 mM 5-HD was infused into the right lateral ventricle over
20 s, 5 min before the treatment with the high dose of diazoxide
(n = 6).
CBF assessment during MCAO. CBF was measured on the right front parietal cortex with a laser Doppler flowmeter (Multichannel Laser Doppler System, PERIMED) during resting conditions, during ischemia, and during reperfusion in two groups of rats. MABP was also measured during the same conditions. We have used these procedures previously (37). One group of rats received 2 mM in 30 µl saline infused into the right lateral ventricle before MCAO (n = 6). Another six sham animals received either saline alone (n = 2) or DMSO in saline (n = 4) infused into the right lateral ventricle before MCAO.
Statistical analysis. Data are expressed as means ± SE. The physiological parameters among different treatment groups were compared by one-way ANOVA. Neurological score was compared among all treatment groups 24 h after ischemia by one-way ANOVA followed by Fisher least-significant-difference post hoc analysis. The percent infarction was compared among different treatments by one-way ANOVA followed by Fisher least-significant-difference post hoc analysis or t-test, whichever was appropriate. A P value <0.05 was regarded as statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Immunoblotting.
Both necessary subunits, which are required for a functional
KATP channel, were found in isolated brain mitochondria.
The specific antibody for the inwardly rectifying K+
channel (Kir6.1) recognized a single band of ~50 kDa (Fig.
1B). This band is enriched in
mitochondria, showing that the primary localization of the Kir6.1
subunit in the brain is in this organelle. Similarly, the anti-SUR2
antibody recognized a specific band of ~130 kDa, which was also
enriched in the mitochondria compared with the full brain tissue level
(Fig. 1A). We also compared the amounts of intact Kir6.1-
and SUR2-immunoreactive bands in the territory affected by MCAO with
the contralateral, nonischemic side. However, we were unable to
detect any substantial differences in the intensity of the bands from
either side for either subunit (data not presented).
|
Fluorescent study.
Autofluorescence was negligible before application of rhodamine-1,2,3.
During baseline conditions, the mitochondria showed a weak fluorescent
signal with rhodamine-1,2,3 (Fig.
2A). The addition of diazoxide
increased the intensity of fluorescence, indicating a decrease in
pH
(Fig. 2B). As a positive control, we added the ionophore
nigericin. Nigericin fully converts
pH to 
m and
maximizes the fluorescent signal (data not shown). Thus the addition of
diazoxide markedly alters mitochondrial function through the
depolarization of the inner membrane.
|
MCAO. In all animals studied, the systemic physiological parameters measured were kept within the normal range throughout the manipulations. The treatment groups did not differ with respect to rectal temperature, blood gases, glucose, or blood pressure (data not shown).
The neurological score 24 h after reperfusion showed a reduced data value for the sham group (Fig. 3). Although not significant, pretreatment with 0.4 mM diazoxide tended to increase the neurological score. Pretreatment with 2 mM diazoxide significantly improved the neurological score compared with sham animals. In contrast, coapplication of 5-HD abolished the effect of 2 mM diazoxide and reduced the neurological score to values similar to sham animals.
|
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The major new finding from the present experiments is that the
pretreatment with the mitoKATP channel opener diazoxide had a neuroprotective effect against transient focal cerebral
ischemia in the rat. While decreases in infarct volume were
particularly prominent in the cerebral cortex, significant
neuroprotection also occurred in subcortical areas. The neuroprotective
effects of diazoxide were reversed by coadministration of 5-HD.
Additionally, data from isolated mitochondria provide evidence that the
obligatory subunits of KATP channels are present in these
organelles and that diazoxide-induced dissipation of

m may be involved in this protective effect. Finally,
CBF responses to ischemia and reperfusion were unaffected
by diazoxide treatment. Thus the selective targeting of the
mitoKATP channel appears to lessen the impact of
ischemic insult to the brain.
The current study supports and extends earlier results from studies in our laboratory and from another laboratory. In the first study, we found that diazoxide treatment given before 10 min of global ischemia preserved normal dilator responses of cortical arterioles to topical application of N-methyl-D-asparate (NMDA) (13). Application of NMDA induces dilation via production of nitric oxide (NO) by cortical neurons and subsequent diffusion of NO to surface arterioles, where NO relaxes vascular smooth muscle cells (13). Typically, ischemia-reperfusion dramatically decreases arterial dilation to NMDA via a mechanism involving altered function of NMDA receptors located on neurons. In the second study, diazoxide treatment protected cortical cells in brain slices during 30 min of anoxia (4). Limitations of these studies are that only immediate effects (30-60 min) and not long-term effects of anoxia were examined and the responses of noncortical cells were not investigated. Furthermore, in the latter study, it is unclear whether diazoxide treatment prevented or simply prolonged survival of neocortical cells, because under anoxic conditions without reoxygenation it is expected that all neurons would eventually die. These initial studies provide circumstantial evidence for the participation of mitoKATP channels in neuroprotection.
The combination of several different approaches in the present study provides the first direct evidence for an important role of the mitoKATP channel in limiting the neurological injury due to MCAO. Administration of diazoxide, a specific activator of mitoKATP channels, limited the extent of death of both cortical and subcortical neurons against 90 min of ischemia induced by transient MCAO (10, 20, 31). Thus, 24 h after reperfusion, dramatic reductions in infarct volume were seen in diazoxide-treated animals compared with sham animals. Furthermore, coadministration of 5-HD, a highly selective antagonist of mitoKATP channels, completely reversed neuroprotection (15, 20, 31). Brain infarct volume was similar in animals receiving vehicle or 5-HD alone before ischemia (unpublished observations). In addition, we found that both obligatory subunits required for a functional KATP channel were found in isolated brain mitochondria. The specific antibody for the inwardly rectifying K+ channel (Kir6.1) recognized a single band of ~50 kDa. Similarly, the specific antibody against SUR2 recognized a specific band of ~130 kDa. These bands are enriched in mitochondria compared with brain tissue, indicating the importance of these K+ channels to function of these organelles. The molecular masses for these subunits are comparable with values reported by other investigators (1, 4, 5, 47). Additionally, fluorescent approaches established the ability of diazoxide to depolarize mitochondria.
Although we (45) and other investigators (4, 18,
43) have shown that nonspecific K+ channel agonists
have similar protective effects, we believe that this is the first
report of the administration of a selective mitoKATP
channel opener increasing neuronal survival after transient brain
ischemia (43). However, precise mechanisms by
which mitoKATP channel activation protects the brain are
unclear. We believe that indirect protective effects via increases in
CBF are unlikely, because our previous studies indicate that diazoxide
does not affect tone of cerebral arteries (13), and the
present results indicate that CBF responses during and after
ischemia are similar in diazoxide-treated and sham animals. One
possible mechanism is that acute activation of mitoKATP
channel results in K+ influx, organelle depolarization, and
expansion of mitochondrial matrix volume. The results of our
fluorescent experiments provide direct evidence that diazoxide can
decrease 
m in brain mitochondria. Regulation of
matrix volume is an essential element in the regulation of
mitochondrial energy production. For example, matrix expansion has been
postulated to activate electron transport and stimulate mitochondrial
metabolism, which may "cushion" cells against transient ischemic events (15, 22). Additionally,
mitochondrial membrane depolarization induced by K+ influx
through mitoKATP channels is expected to dissipate

m and thereby decrease Ca2+ influx during
ischemia. Thus the driving force for Ca2+ influx
through the Ca2+ uniport is reduced, consequently
attenuating mitochondrial Ca2+ overload (12, 14,
23). Mitochondrial Ca2+ overload has been closely
correlated with mitochondrial damage, which results in both necrotic
and apoptotic forms of cell death (2, 8, 23, 40, 44).
For example, the accumulation of Ca2+ in mitochrondria
damages complex I of the electron transport chain (22),
increases production of reactive oxygen species, and causes formation
of mitochondrial permeability transition pores, all of which can lead
to cell death (6, 11, 25, 33). Thus, in addition to
increasing energy production before ischemia, diazoxide
treatment may also protect neurons by attenuating or delaying
mitochondrial Ca2+ overload.
In conclusion, the present study has provided the first direct evidence that selective opening of the mitoKATP channel provides neuroprotection against ischemia-reperfusion in the rat brain. Thus, despite profound differences in cellular physiology and sensitivity to anoxic injury between myocardial cells and neurons, the same pharmacological approach has been shown to protect the heart and brain, respectively, against ischemia-reperfusion injury.
| |
ACKNOWLEDGEMENTS |
|---|
This research was supported by National Heart, Lung, and Blood Institute Grants HL-30260, HL-46558, and HL-50587, American Heart Association (AHA) Mid-Atlantic Affiliate Grant 99512724, and AHA Bugher Foundation Award 0270114. N. Z. Lacza was partially supported by the Hungarian National Eötvös Fellowship.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: K. Shimizu, Dept. of Neurosurgery, Tachikawa Hospital, 4-2-22 Nishikicho Tachikawa-shi, Tokyo 190-8531, Japan (E-mail: KATSUYOSHIS{at}aol.com).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
May 16, 2002;10.1152/ajpheart.00054.2002
Received 22 January 2002; accepted in final form 7 May 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Aguilar-Bryan, L,
and
Bryan J.
Molecular biology of adenosine triphosphate-sensitive potassium channels.
Endocr Rev
20:
101-135,
1999
2.
Akao, M,
Ohler A,
O'Rourke B,
and
Marbán E.
Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells.
Circ Res
88:
1267-1275,
2001
3.
Anderson, MF,
and
Sims NR.
Mitochondrial respiratory function and cell death in focal cerebral ischemia.
J Neurochem
73:
1189-1199,
1999[Web of Science][Medline].
4.
Arriba, SG,
Franke H,
Pissarek M,
Nieber K,
and
Illes P.
Neuroprotection by ATP-dependent potassium channels in rat neocortical brain slices during hypoxia.
Neurosci Lett
273:
13-16,
1999[Web of Science][Medline].
5.
Bajgar, R,
Seetharaman S,
Kowaltowski AJ,
Garlid KD,
and
Paucek P.
Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain.
J Biol Chem
276:
33369-33374,
2001
6.
Buja, LM.
Modulation of the myocardial response to ischemia.
Lab Invest
78:
1345-1373,
1998[Web of Science][Medline].
7.
Busija, DW,
Shimizu K,
and
Rajapakse N.
Selective activation of mitochodrial ATP-sensitive potassium channels by diazoxide limits infarct volume following transient focal cerebral ischemia in rats.
Circulation
104:
II-175,
2001.
8.
Crompton, M.
The mitochondrial permeability transition pore and its role in cell death.
J Biochem
341:
127-132,
1999.
9.
Cui, JK,
Hsu CY,
and
Liu PK.
Suppression of postischemic hippocampal nerve growth factor expression by a c-fos antisense oligodeoxynucleotide.
J Neurosci
19:
1335-1344,
1999
10.
D
bska, G,
May R,
Kici
ska A,
Szewczyk A,
Elger CE,
and
Kunz WS.
Potassium channel openers depolarize hippocampal mitochondria.
Brain Res
892:
42-50,
2001[Web of Science][Medline].
11.
Di Lisa, F,
and
Bernardi P.
Mitochondrial function as a determinant of recovery or death in cell response to injury.
Mol Cell Biochem
184:
379-391,
1998[Web of Science][Medline].
12.
Di Lisa, F,
Manabo R,
Canton M,
and
Petronilli V.
The role of mitochondria in the salvage and injury of the ischemic myocardium.
Biochim Biophys Acta
1366:
69-78,
1998[Medline].
13.
Domoki, F,
Perciaccante JV,
Veltkamp R,
Bari F,
and
Busija DW.
Mitochondrial potassium channel opener diazoxide preserves neuronal-vascular function after cerebral ischemia in newborn pigs.
Stroke
30:
2713-2719,
1999
14.
Ferrari, R.
The role of mitochondria in ischemic heart disease.
J Cardiovasc Pharmacol
28, Suppl1:
S1-S10,
1996[Web of Science][Medline].
15.
Fryer, RM,
Eells JT,
Hsu AK,
Henry MM,
and
Gross GJ.
Ischemic preconditioning in rats: role of mitochondrial KATP channel in preservation of mitochondrial function.
Am J Physiol Heart Circ Physiol
278:
H305-H312,
2000
16.
Garcia, JH,
Wagner S,
Liu KF,
and
Hu XJ.
Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation.
Stroke
26:
627-635,
1995
17.
Garlid, KD,
Paucek P,
Yarov-Yarovoy V,
Murray HN,
Darbenzio RB,
D'Alonzo AJ,
Lodge NJ,
Smith MA,
and
Grover GJ.
Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels.
Circ Res
81:
1072-1082,
1997
18.
Gribkoff, VK,
Starrett JE, Jr,
Dworetzky SI,
Hewawasam P,
Boissard CG,
Cook DA,
Frantz SW,
Heman K,
Hibbard JR,
Huston K,
Johnson G,
Krishnan BS,
Kinney GG,
Lombardo LA,
Meanwell NA,
Molinoff PB,
Myers RA,
Moon SL,
Ortiz A,
Pajor L,
Pieschl RL,
Post-Munson DJ,
Signor LJ,
Srinivas N,
Taber MT,
Thalody G,
Trojnacki JT,
Wiener H,
Yeleswaram K,
and
Yeola SW.
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels.
Nat Med
7:
471-477,
2001[Web of Science][Medline].
19.
Griffiths, JE.
Mitochondria-potential role in cell life and death.
Cardiovasc Res
46:
24-27,
2000
20.
Gross, GJ,
and
Fryer RM.
Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning.
Circ Res
84:
973-979,
1999
21.
Grover, GJ,
Dzwonczyk S,
and
Sleph PG.
Reduction of ischemic damage in isolated rat hearts by the potassium channel opener RP 52891.
Eur J Pharmacol
191:
11-19,
1990[Web of Science][Medline].
22.
Halestrap, AP.
Regulation of mitochondrial metabolism through changes in matrix volume.
Biochem Soc Trans
22:
522-529,
1994[Web of Science][Medline].
23.
Halestrap, AP,
Kerr PM,
Javadov S,
and
Woodfield KY.
Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart.
Biochim Biophys Acta
1366:
79-94,
1998[Medline].
24.
Hardy, L,
Clark J,
Darley-Usmar V,
Smith D,
and
Stone D.
Reoxygenation dependent decrease in mitochondrial NADH: CoQ reductase (Complex I) activity in the hypoxic/reoxygenated rat heart.
J Biochem
274:
133-137,
1991.
25.
Kristián, T,
and
Siesjö BK.
Calcium in ischemic cell death.
Stroke
29:
705-718,
1998
26.
Kroemer, G,
Dallaporta B,
and
RescheRigon M.
The mitochondrial death/life regulator in apoptosis and necrosis.
Annu Rev Physiol
60:
619-642,
1998[Web of Science][Medline].
27.
Lacza, Z,
Puskar M,
Figueroa JP,
Zhang J,
Rajapakse N,
and
Busija DW.
Mitochondrial nitric oxide synthase is constitutively active and is functionally upregulated in hypoxia.
Free Radic Biol Med
31:
1609-1615,
2001[Web of Science][Medline].
28.
Lin, TN,
He YY,
Wu G,
Khan M,
and
Hsu CY.
Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats.
Stroke
24:
117-121,
1993
29.
Lisa, FD,
and
Bernardi P.
Mitochondrial function as a determinant of recovery or death in cell response to injury.
Mol Cell Biochem
184:
379-391,
1998[Web of Science][Medline].
30.
Liu, Y,
Sato T,
O'Rourke B,
and
Marban E.
Mitochondrial ATP-dependent potassium channels. Novel effectors of cardioprotection?
Circulation
97:
2463-2469,
1998
31.
Ockaili, R,
Emani VR,
Okubo S,
Brown M,
Krottapalli K,
and
Kukreja RC.
Opening of mitochondrial KATP channel induces early and delayed cardioprotective effect: role of nitric oxide.
Am J Physiol Heart Circ Physiol
277:
H2425-H2434,
1999
32.
Paxinos, G,
and
Watson C.
The Rat Brain in Stereotactic Coordinates (2nd ed.). Sydney, Australia: Academic, 1986.
33.
Piot, CA,
Padmanaban D,
Ursell PC,
Sievers RE,
and
Wolfe CL.
Ischemic preconditioning decreases apoptosis in rat hearts in vivo.
Circulation
96:
1598-1604,
1997
34.
Rajapakse, N,
Shimizu K,
Payne M,
and
Busija DW.
Isolation and characterization of intact mitochondria from neonatal rat brain.
Brain Res
8:
176-183,
2001.
35.
Sargent, CA,
Smith MA,
Dzwonczyk S,
Sleph PG,
and
Grover GJ.
Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents.
J Pharmacol Exp Ther
259:
97-103,
1991
36.
Sarti, P,
Lendaro E,
Ippoliti R,
Bellelli A,
Benedetti PA,
and
Brunori M.
Modulation of mitochondrial respiration by nitric oxide: investigation by single cell fluorescence microscopy.
FASEB J
13:
191-197,
1999
37.
Shimizu, K,
Miller AW,
Erdös Bari F,
and
Busija DW.
Role of endothelium in hyperemia during cortical spreading depression in the rat.
Brain Res
928:
40-49,
2002[Web of Science][Medline].
38.
Shimizu, K,
Rajapakse N,
and
Busija DW.
Neuroprotective effects of diazoxide, a selective opener of mitochondrial ATP-sensitive potassium channels, against transient focal cerebral ischemia in rats.
Soc Neurosci Abstr
27:
Program 332.11,
2001.
39.
Shimizu, K,
Veltkamp R,
and
Busija DW.
Characteristics of induced spreading depression after transient focal ischemia in the rat.
Brain Res
861:
316-324,
2000[Web of Science][Medline].
40.
Siesjö, BK,
Elmér E,
Janelidze S,
Keep M,
Kristián T,
Ouyang YB,
and
Uchino H.
Role and mechanisms of secondary mitochondrial failure.
Acta Neurochir
73, Suppl:
7-13,
2000.
41.
Sims, NR.
Rapid isolation of metabolically active mitochondria from rat brain and subregions using Percoll density gradient centrifugation.
J Neurochem
55:
698-707,
1990[Web of Science][Medline].
42.
Swanson, RA,
Morton MT,
Wu TG,
Savalos RA,
Davidson C,
and
Sharp FR.
A semiautomated method for measuring brain infarct volume.
J Cereb Blood Flow Metab
10:
290-293,
1990[Web of Science][Medline].
43.
Takaba, H,
Nagao T,
Yao H,
Kitazono T,
Ibayashi S,
and
Fujishima M.
An ATP-sensitive potassium channel activator reduces infarct volume in focal cerebral ischemia in rats.
Am J Physiol Regul Integr Comp Physiol
273:
R583-R586,
1997
44.
Takashi, E,
Wang Y,
and
Ashraf M.
Activation of mitochondrial KATP channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway.
Circ Res
85:
1146-1153,
1999
45.
Veltkamp, R,
Domoki F,
Bari F,
and
Busija DW.
Potassium channel activators protect the N-methyl-D-asparate-induced cerebral vascular dilation after combined hypoxia and ischemia in piglets.
Stroke
29:
837-842,
1998
46.
Veltkamp, R,
Warner DS,
Domoki F,
Brinkhous AD,
Toole JF,
and
Busija DW.
Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats.
Brain Res
853:
68-73,
2000[Web of Science][Medline].
47.
Yamada, M,
Isomoto S,
Matsumoto S,
Kondo C,
Shindo T,
Horio Y,
and
Kurachi Y.
Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel.
J Physiol
499:
715-720,
1997
This article has been cited by other articles:
![]() |
M. E. Pamenter, D. S.-H. Shin, M. Cooray, and L. T. Buck Mitochondrial ATP-sensitive K+ channels regulate NMDAR activity in the cortex of the anoxic western painted turtle J. Physiol., February 15, 2008; 586(4): 1043 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Obrenovitch Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia Physiol Rev, January 1, 2008; 88(1): 211 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Sun, Z.-P. Feng, T. Miki, S. Seino, and R. J. French Enhanced Neuronal Damage After Ischemic Insults in Mice Lacking Kir6.2-Containing ATP-Sensitive K+ Channels J Neurophysiol, April 1, 2006; 95(4): 2590 - 2601. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Brustovetsky, N. Shalbuyeva, and N. Brustovetsky Lack of manifestations of diazoxide/5-hydroxydecanoate-sensitive KATP channel in rat brain nonsynaptosomal mitochondria J. Physiol., October 1, 2005; 568(1): 47 - 59. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |